If you ever encounter a fanatic mitochondriac trying to convince you that mitochondria are the powerhouse of the cell and the most fascinating element of your body—don’t be fooled.
Mitochondria are way more than powerhouses…
Diffuse their delusion: https://t.co/aBpYCzptwE
A team of researchers at the @ImmunologyAU identified five immune targets that may help explain how CD8+ T cells contribute to atherosclerosis. The findings could help advance research into targeted therapies for cardiovascular disease.
https://t.co/398CPbbMPy
Our center will be well represented at #Neutrophil2026 with oral presentations by Lynn Hedrick, PhD, Peipei Zhu, PhD, and Klaus Ley, MD, and poster presentations by Austin Lowery and Gabriel Valentín Guillama, PhD.
@TheHedrickLab#Neutrophil#Immunology#Research
Thank you to @VirusesImmunity, for serving as the keynote speaker for the Inaugural Margaret-Gertraud Immunology Lectureship. Her presentation, "Science Behind Failure to Recover from Infections," shared insights about the work she has contributed to several long COVID studies.
As we close in on the end of this year's Women's History Month, @LynnHedrickAU shared about the many women who have influenced her career, from her postdoctoral mentor at UCLA to some of the pillars of women in STEM.
A couple weeks ago, members of IMMCG traveled to Bellevue, Washington, for ATVB's annual Vascular Discover 2026 Scientific Sessions. Klaus Ley, MD, presented, Ravi Komaravolu, PhD, (@angiogen) presented his poster, and our group was featured in the @American_Heart email!
Ravi Komaravolu, PhD, (@angiogen) and Lynn Hedrick, PhD, will serve as topic editors for an upcoming edition of "Frontiers In Aging." The topic will be Myeloid Heterogeneity in Inflammaging.
Learn more or submit here: https://t.co/s6ubmnlAMo
#immunology#inflammaging
IMMCG hosted the first-ever Ignite Grant ceremony this week. Gang Zhou, PhD, gave a project update, and guests explored 9 exciting 2026 proposals during a poster session. 🔬✨
📸 More photos - https://t.co/AIP65sxGj9
@ga_res_alliance@AUG_University#Immunology#Ignite2026
Why do some melanoma patients respond to immunotherapy while others don't? Elayne Brown investigates an unexpected immune receptor that could help predict treatment success.
https://t.co/YdiI2bSdKA
@MarcoOrecchioni#Melanoma#SkinCancer#Immunotherapy
Every big journey begins with a single step; celebrating a major milestone makes that first step even sweeter. We are thrilled to officially welcome you to our digital space! This marks our very first post, and the timing couldn't be more perfect. @ImmunologyAU@LynnHedrickAU